Search results for "biodistribution"

showing 10 items of 94 documents

Impact of Heavy Metals in Eggs and Tissues of C. caretta along the Sicilian Coast (Mediterranean Sea)

2022

In this study we compared the heavy metal concentration found in different tissues and eggs of the loggerhead sea turtle and evaluated the potential ecotoxicological risk for this important species. Eighteen heavy metal elements were determined in different tissues (liver, gonads, fat, kidney, heart, brain, and spleen) of nine individuals of Caretta caretta found stranded along the coasts of Messina (Sicily, Italy) and in the shell and yolk of six eggs from the island of Linosa (Sicily, Italy). For the analysis of the heavy metals, we used the analytical procedures in accordance with the EPA 200.8 method supplemented by EPA 6020b with three replicates for each measurement. The elements anal…

Settore BIO/07 - Ecologialoggerhead sea turtleCaretta carettaRenewable Energy Sustainability and the EnvironmentMediterranean seaSettore BIO/05 - Zoologiaheavy metalloggerhead sea turtle; <i>Caretta caretta</i>; marine pollution; heavy metals; biodistribution; Mediterranean seabiodistributionEcology Evolution Behavior and SystematicsSettore CHIM/12 - Chimica Dell'Ambiente E Dei Beni CulturaliGeneral Environmental Sciencemarine pollution
researchProduct

Detoxifying antitumoral drugs via nanoconjugation: the case of gold nanoparticles and cisplatin

2021

Nanoparticles (NPs) have emerged as a potential tool to improve cancer treatment. Among the proposed uses in imaging and therapy, their use as a drug delivery scaffold has been extensively highlighted. However, there are still some controversial points which need a deeper understanding before clinical application can occur. Here the use of gold nanoparticles (AuNPs) to detoxify the antitumoral agent cisplatin, linked to a nanoparticle via a pH-sensitive coordination bond for endosomal release, is presented. The NP conjugate design has important effects on pharmacokinetics, conjugate evolution and biodistribution and results in an absence of observed toxicity. Besides, AuNPs present unique o…

Time FactorsCancer TreatmentMetal Nanoparticleslcsh:MedicinePharmacologyMiceNanotechnologyTissue Distributionlcsh:Sciencemedia_commonDrug DistributionDrug CarriersMultidisciplinaryChemistryDNA NeoplasmOrgan SizeHydrogen-Ion ConcentrationEndocytosisOncologyColloidal goldDrug deliveryInactivation MetabolicMedicinemedicine.drugResearch ArticleBiotechnologyDrugBiodistributionDrugs and Devicesmedia_common.quotation_subjectMaterials ScienceAntineoplastic AgentsMaterial by AttributePharmacokineticsCell Line TumormedicineAnimalsHumansPharmacokineticsBiologyNanomaterialsCisplatinUnited States Food and Drug Administrationlcsh:RChemotherapy and Drug TreatmentUnited StatesBionanotechnologylcsh:QGoldNanocarriersCisplatinConjugate
researchProduct

Radioactive labeling of defined HPMA-based polymeric structures using [18F]FETos for in vivo imaging by positron emission tomography.

2009

During the last decades polymer-based nanomedicine has turned out to be a promising tool in modern pharmaceutics. The following article describes the synthesis of well-defined random and block copolymers by RAFT polymerization with potential medical application. The polymers have been labeled with the positron-emitting nuclide fluorine-18. The polymeric structures are based on the biocompatible N-(2-hydroxypropyl)-methacrylamide (HPMA). To achieve these structures, functional reactive ester polymers with a molecular weight within the range of 25,000-110,000 g/mol were aminolyzed by 2-hydroxypropylamine and tyramine (3%) to form (18)F-labelable HPMA-polymer precursors. The labeling procedure…

chemistry.chemical_classificationBiodistributionAcrylamidesFluorine RadioisotopesPolymers and PlasticsPolymersRadical polymerizationSize-exclusion chromatographyRadiochemistryBioengineeringChain transferPolymerPolymerizationRatsBiomaterialsPolymerizationchemistryIsotope LabelingPositron-Emission TomographyPolymer chemistryMaterials ChemistryAnimalsReversible addition−fragmentation chain-transfer polymerizationPreclinical imagingBiotransformationBiomacromolecules
researchProduct

A Novel Series of 2-Carboxytetrahydroquinolines Provides New Insights into the Eastern Region of Glycine Site NMDA Antagonists

2000

A series of potent 4-substituted tetrahydroquinolines has been synthesized and biologically tested in order to refine the eastern region of the pharmacophore model for glycine site NMDA antagonists concerning the assessment of lipophilicity, flexibility, and hydrogen bonding. Displacement studies on rat cortical membranes using [ 3 H]-5,7-dichlorokynurenic acid as a radioligand indicated that binding affinities are markedly enhanced when additional hydrogen-accepting groups are introduced into the eastern region of the 2-carboxytetrahydroquinolines. Among the most potent ligands were some urea, sulfonylurea, and crown ether compounds as interesting leads for new diagnostics, especially for …

chemistry.chemical_classificationBiodistributionChemistryStereochemistryDrug DiscoveryGlycineLipophilicityRadioligandPharmaceutical ScienceNMDA receptorPharmacophoreGlycine receptorCrown etherArchiv der Pharmazie
researchProduct

Synthesis and biopharmaceutical characterisation of new poly(hydroxyethylaspartamide) copolymers as drug carriers.

2001

Abstract Four new poly(hydroxyethylaspartamide)-based copolymers bearing (a) poly(ethylene glycol) 2000, (b) poly(ethylene glycol) 5000, (c) poly(ethylene glycol) 2000 and hexadecylalkyl, (d) poly(ethylene glycol) 5000 and hexadecylalkyle, as pendant groups were synthesised. The copolymers were obtained by partial aminolysis of polysuccinimide with poly(ethylene glycol) and hexadecylalkyl amino derivatives followed by reaction with ethanolamine. Naked polyhydroxyaspartamide was obtained by polysuccinimide reaction with ethanolamine. The nuclear magnetic resonance, infrared, light scattering and elemental analysis allowed for the extensive physico-chemical characterisation of the carriers. T…

chemistry.chemical_classificationBiodistributionDrug CarriersMagnetic Resonance SpectroscopySpectrophotometry InfraredPolymersBiophysicsPolymerBiochemistryPolyethylene Glycolschemistry.chemical_compoundMiceAminolysisEthanolaminechemistryNeoplasmsPolymer chemistryCopolymerAnimalsTissue DistributionDrug carrierPeptidesMolecular BiologyEthylene glycolConjugateBiochimica et biophysica acta
researchProduct

Long-term biodistribution study of HPMA- ran -LMA copolymers in vivo by means of 131 I-labeling

2018

Abstract Background For the evaluation of macromolecular drug delivery systems suitable pre-clinical monitoring of potential nanocarrier systems is needed. In this regard, both short-term as well as long-term in vivo tracking is crucial to understand structure-property relationships of polymer carrier systems and their resulting pharmacokinetic profile. Based on former studies revealing favorable in vivo characteristics for 18 F–labeled random (ran) copolymers consisting of N-(2-hydroxypropyl)methacrylamide (HPMA) and lauryl methacrylate (LMA) – including prolonged plasma half-life as well as enhanced tumor accumulation – the presented work focuses on their long-term investigation in the li…

chemistry.chemical_classificationCancer ResearchBiodistribution02 engineering and technologyPolymer010402 general chemistry021001 nanoscience & nanotechnology01 natural sciences0104 chemical scienceschemistry.chemical_compoundchemistryIn vivoCritical micelle concentrationBiophysicsMolecular MedicineDistribution (pharmacology)MethacrylamideRadiology Nuclear Medicine and imagingNanocarriers0210 nano-technologyEx vivoNuclear Medicine and Biology
researchProduct

On the applicability of [18F]FBPA to predict L-BPA concentration after amino acid preloading in HuH-7 liver tumor model and the implication for liver…

2017

Abstract Introduction In recent years extra-corporal application of boron neutron capture therapy (BNCT) was evaluated for liver primary tumors or liver metastases. A prerequisite for such a high-risk procedure is proof of preferential delivery and high uptake of a 10 B-pharmaceutical in liver malignancies. In this work we evaluated in a preclinical tumor model if [ 18 F]FBPA tissue distribution measured with PET is able to predict the tissue distribution of [ 10 B]L-BPA. Methods Tumor bearing mice (hepatocellular carcinoma cell line, HuH-7) were either subject of a [ 18 F]FBPA-PET scan with subsequent measurement of radioactivity content in extracted organs using a gamma counter or injecte…

chemistry.chemical_classificationCancer ResearchBiodistributionPathologymedicine.medical_specialtyLiver tumorChemistryChemical structuremedicine.disease030218 nuclear medicine & medical imagingAmino acid03 medical and health sciences0302 clinical medicinemedicine.anatomical_structurePharmacokinetics030220 oncology & carcinogenesisHepatocellular carcinomamedicineCancer researchMolecular MedicineRadiology Nuclear Medicine and imagingPancreasGamma counterNuclear Medicine and Biology
researchProduct

Biodistribution of Insulin-Nanogels in Mouse: A Preliminary Study for the Treatment of Alzheimer's Disease

2017

A growing body of evidence shows that Insulin, Insulin Receptor (IR) and IR signaling are involved in brain cognitive functions and their dysfunction is implicated in Alzheimer's disease (AD) neurodegeneration. Thus, administration of insulin could be a strategy for AD treatment. For this aim we have designed, synthesized and characterized a nanogel system (NG) that has been conjugated to insulin molecules (NG-In) to deliver the protein into the brain, as a tool for the development of a new therapy against AD. In our preclinical study in mice, intraperitoneal injection of fluorescent-labeled NG has allowed to determine the biodistribution of NG vs time in the whole body and its clearance th…

insulinBiodistributionmedicine.medical_treatmentIntraperitoneal injectionBiophysics02 engineering and technologyPharmacology010402 general chemistrySettore BIO/09 - Fisiologia01 natural sciencesintranasal administrationnanogelsTreatment of Alzheimer's DiseasemedicineDistribution (pharmacology)biologybusiness.industryInsulinNeurodegeneration021001 nanoscience & nanotechnologymedicine.diseaseSettore FIS/07 - Fisica Applicata(Beni Culturali Ambientali Biol.e Medicin)0104 chemical sciencesInsulin receptorImmunologybiology.proteinNasal administrationSettore CHIM/07 - Fondamenti Chimici Delle TecnologieAlzheimer disease0210 nano-technologybusinessNanogelBiophysical Journal
researchProduct

Bone targeting compounds for radiotherapy and imaging: *Me(III)-DOTA conjugates of bisphosphonic acid, pamidronic acid and zoledronic acid

2016

Background Bisphosphonates have a high adsorption on calcified tissues and are commonly used in the treatment of bone disorder diseases. Conjugates of bisphosphonates with macrocyclic chelators open new possibilities in bone targeted radionuclide imaging and therapy. Subsequent to positron emission tomography (PET) examinations utilizing 68Ga-labelled analogues, endoradiotheraphy with 177Lu-labelled macrocyclic bisphosphonates may have a great potential in the treatment of painful skeletal metastases. Methods Based on the established pharmaceuticals pamidronate and zoledronate two new DOTA-α-OH-bisphosphonates, DOTAPAM and DOTAZOL(MM1.MZ) were successfully synthesized. The ligands were labe…

lcsh:Medical physics. Medical radiology. Nuclear medicineBiodistributionMaterials sciencelcsh:R895-920Hydroxy bisphosphonatesSingle-photon emission computed tomography01 natural sciences030218 nuclear medicine & medical imagingAnalytical Chemistry03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePharmacokineticsmedicineDOTAPharmacology (medical)Radiology Nuclear Medicine and imagingZoledronic acidPharmacologymedicine.diagnostic_test010405 organic chemistrybusiness.industryResearchBone metastaseslcsh:RM1-950Pamidronic acid177LuTheranostics68Ga0104 chemical sciencesZoledronic acidPETlcsh:Therapeutics. PharmacologyDOTAchemistryPositron emission tomographyNuclear medicinebusinessEx vivomedicine.drugEJNMMI Radiopharmacy and Chemistry
researchProduct

Evaluation of the inverse electron demand Diels-Alder reaction in rats using a scandium-44-labelled tetrazine for pretargeted PET imaging

2019

Background Pretargeted imaging allows the use of short-lived radionuclides when imaging the accumulation of slow clearing targeting agents such as antibodies. The biotin-(strept)avidin and the bispecific antibody-hapten interactions have been applied in clinical pretargeting studies; unfortunately, these systems led to immunogenic responses in patients. The inverse electron demand Diels-Alder (IEDDA) reaction between a radiolabelled tetrazine (Tz) and a trans-cyclooctene (TCO)-functionalized targeting vector is a promising alternative for clinical pretargeted imaging due to its fast reaction kinetics. This strategy was first applied in nuclear medicine using an 111In-labelled Tz to image TC…

lcsh:Medical physics. Medical radiology. Nuclear medicineBiodistributionlcsh:R895-920Tetrazine010402 general chemistry01 natural sciencesChemical kineticsTetrazinechemistry.chemical_compoundMedicineDOTARadiology Nuclear Medicine and imagingPretargeted imagingInverse electron-demand Diels–Alder reactionAlendronic acidOriginal ResearchPretargetingTrans-cyclooctene (TCO)biologymedicine.diagnostic_test010405 organic chemistrybusiness.industryScandium-44 (44Sc)RadiochemistryBisphosphonates0104 chemical sciences3. Good healthchemistryPositron emission tomographyPositron emission tomography (PET)biology.proteinInverse electron demand Diels-Alder (IEDDA)businessAvidinEJNMMI Research
researchProduct